Capvizr

B Capital Raises $500 million Series A

Company profile · Healthcare & Life Sciences · Updated July 7, 2026

B Capital closed its third early-stage fund at a $500 million hard cap, exceeding its original target. “AI is creating extraordinary opportunities across every industry,” Howard Morgan, chair and general partner at B Capital, said in the announcement.

Series A$500 millionTotal tracked $500 millionUndisclosed HQ

What it does

B Capital closed its third early-stage fund at a $500 million hard cap, exceeding its original target. “AI is creating extraordinary opportunities across every industry,” Howard Morgan, chair and general partner at B Capital, said in the announcement.

Traction

Ascent Fund III participated in the latest tracked round; deeper traction analysis is held until source support is strong enough.

Trend impact

MD-grade thesis held: available source material is not specific enough to support a non-generic investor-economist read without overclaiming.

Funding history

  • July 7, 2026 · Series A · $500 million · Ascent Fund III
Open B Capital in the interactive Capvizr dashboard →